Investment Stage

Focus Areas

About Investor

Katya Smirnyagina is a Senior Partner and Head of Life Sciences at Oxford Science Enterprises. Based in Oxford, she focuses on BioTech companies raising Seed, Series A, and Series B financing. Her investment work follows scientific discoveries from their earliest commercial potential through the creation and growth of venture-backed businesses. She manages opportunities ranging from $650K to $26M, with a preferred investment of around $6M. As a lead investor, she is involved in scientific assessment, company formation, transaction structuring, and long-term portfolio strategy. Her role requires balancing scientific ambition with clinical, regulatory, and commercial realities. At Oxford Science Enterprises, she helps life-sciences founders turn research breakthroughs into scalable biotechnology companies.